Susceptibility of Streptococcus mutans and Actinobacillus actinomycetemcomitans to bactericidal activity of human β-defensin 3 in biological fluids

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 3, 2005, Pages 1245-1248

  Maisetta, Giuseppantonio ^a   Batoni, Giovanna ^a   Esin, Semih ^a   Raco, Giorgio ^a   Bottai, Daria ^a   Favilli, Flavia ^a   Florio, Walter ^a   Campa, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 3; SYNTHETIC DEFENSIN 3; UNCLASSIFIED DRUG;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ARTICLE; BACTERICIDAL ACTIVITY; BODY FLUID; MOUTH INFECTION; NONHUMAN; PRIORITY JOURNAL; SALIVA; SERUM; STREPTOCOCCUS MUTANS; THERAPY;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; AMOXICILLIN; BETA-DEFENSINS; CHLORHEXIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICROBIAL SENSITIVITY TESTS; SALIVA; STREPTOCOCCUS MUTANS;

EID: 14744281431     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.3.1245-1248.2005     Document Type: Article

References (11)

1. Batoni, G., F. Marchetti, F. Ota, E. Ghelardi, S. Barnini, S. Inoue, C. Uchiyama, K. Hirota, Y. Minato, M. R. Giuca, M. Gabriele, M. Campa, and S. Senesi. 1993. First characterization in Italy of clinical isolates of mutans streptococci by using specific monoclonal antibodies. Eur. J. Epidemiol. 9:483-488.
2. Bissell, J., S. Joly, G. K. Johnson, C. C. Organ, D. Dawson, P. B. McCray, and J. M. Guthmiller. 2004. Expression of β-defensins in gingival health and in periodontal disease. J. Oral Pathol. Med. 33:278-285.
3. Ganz, T. 2003. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. 3:710-720.
4. Hancock, R. E. W. 2001. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 1:156-164.
5. Harder, J., J. Bartels, E. Christophers, and J. M. Schroder. 2001. Isolation and characterization of human β-defensin 3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276:5707-5713.
6. Joly, S., C. Maze, P. B. McCray, Jr., and J. M. Guthmiller. 2004. Human β-defensin 2 and 3 demonstrate strain-selective activity against oral microorganisms. J. Clin. Microbiol. 42:1024-1029.
7. Maisetta, G., G. Batoni, S. Esin, F. Luperini, M. Pardini, D. Bottai, W. Florio, M. R. Giuca, M. Gabriele, and M. Campa. 2003. Activity of human β-defensin 3 alone or combined with other antimicrobial agents against oral bacteria. Antimicrob. Agents Chemother. 47:3349-3351.
8. Mosca, D. A., M. A. Hurst, W. So, B. S. C. Viajar, C. A. Fuj II, and T. J. Falla. 2000. IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis. Antimicrob. Agents Chemother. 44:1803-1808.
9. Panyutich, A. V., and T. Ganz. 1991. Activated alpha-2-macroglobulin is a principal defensin-binding protein. Am. J. Respir. Cell Mol. Biol. 5:101-106.
10. Tanaka, D., K. T. Miyasaki, and R. I. Lehrer. 2000. Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: a cathelicidin found in human leukocytes and epithelium. Oral Microbiol. Immunol. 15:226-231.
11. Wang, Y., B. Agerberth, A. Lothgren, A. Almstedt, and J. Johansson. 1998. Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37. J. Biol. Chem. 273:33115-33118.